文献速递主动脉疾病颈动脉与弓上血管

异常右锁骨下动脉(迷走动脉)的当代外科管理

Contemporary Surgical Management of Aberrant Right Subclavian Arteries (Arteria Lusoria).
PubMed 文献 · Ann Vasc Surg · 2020-09-16

单中心回顾性研究纳入8例接受侵入性治疗的异常右锁骨下动脉(ARSA)患者,采用单期或多期手术,技术及临床成功率100%,总死亡率0%。治疗旨在预防动脉瘤破裂并缓解吞咽困难或缺血症状,强调个体化方案。

要点

  • ARSA合并动脉瘤或症状时需侵入性治疗,技术及临床成功率高。
  • 治疗策略包括血管重建、主动脉弓去分支及TEVAR,需个体化。
  • 并发症少见,随访中需关注内漏及动脉瘤进展。

核心结论

  • ARSA的外科管理旨在预防动脉瘤破裂并缓解吞咽困难或缺血症状。
  • 个体化治疗规划在专科中心对获得满意结局至关重要。

研究设计与样本

  • 单中心回顾性研究,2012年1月1日至2018年3月1日,纳入8例接受侵入性治疗的症状性或无症状ARSAA患者。

主要发现

  • 8例患者(4男,63±14岁,范围39-78)接受单期(n=4)或多期(n=4)手术。
  • ARSAA治疗(n=4)包括ARSA血运重建(SCT=3;CSB=1)、主动脉弓去分支(左SCT=2,双侧主动脉-颈动脉旁路+左CSB=1,右向左CSB+左颈动脉至旁路转位=1)及TEVAR(n=4)。
  • 其他策略包括吞咽困难行SCT(n=2)、锁骨下动脉窃血综合征行SCT(n=1)及手臂跛行行球囊血管成形术(n=1)。
  • 并发症涉及血管入路(n=2)、TEVAR期间部分颈总动脉覆膜支架置入无卒中及SCT后Horner综合征各1例。
  • 平均随访23±26(9-67)个月,1例患者7个月后因II型内漏伴ARSAA进展需椎动脉栓塞;总死亡率0%,技术及临床成功率100%。

临床怎么用

  • 对症状性ARSA或ARSAA患者,可考虑个体化的开放手术、杂交或TEVAR策略。
  • 术后需随访监测内漏及动脉瘤进展,必要时再次干预。

局限性

  • 单中心回顾性研究,样本量小(8例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An aberrant right subclavian artery (ARSA) is in most cases an asymptomatic aortic arch anomaly. However, dysphagia, aneurysm formation (ARSAA), associated Kommerell diverticulum, or cerebellar/arm malperfusion may require invasive therapy. Large-scale clinical trials do not exist in current literature. We report our patient's outcome of a single-center experience and delineate indications for treatment and surgical techniques. METHODS: A single-center retrospective study was conducted between January 1, 2012 through March 1, 2018. Symptomatic or asymptomatic patients with ARSAA who received invasive treatment at the Department for Vascular and Endovascular Surgery, University Hospital Dusseldorf, Germany were included. RESULTS: Eight patients (4 men, 63 ± 14 (39-78) years) were treated with single-stage (n = 4) or multistage (n = 4) procedures. Treatment for ARSAA (n = 4) included ARSA revascularization (subclavian-carotid transposition (SCT) = 3; carotid-subclavian bypass (CSB) = 1), aortic arch debranching (left SCT = 2, bilateral aorto-carotid bypass + left CSB = 1, right-to-left CSB + left-carotid-to-bypass transposition = 1), and thoracic endovascular aortic repair (TEVAR; n = 4). Other strategies included SCT for dysphagia (n = 2) or subclavian steal syndrome (n = 1) and balloon angioplasty for arm claudication (n = 1). Complications involved vascular access (n = 2) and each one partial common carotid artery overstenting without stroke during TEVAR and Horner syndrome after SCT. Mean follow-up was 23 ± 26 (9-67) months. After 7 months, 1 patient required vertebral artery coiling due to type II endoleak with ARSAA progression. Overall mortality was 0%. Technical and clinical success rates were 100%. CONCLUSIONS: Surgical concepts for ARSA aim on preventing aneurysm rupture and alleviate dysphagia or ischemic symptoms. To generate satisfying patient outcomes, individualized therapy planning in specialized centers is vital.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dueppers P, Floros N, Schelzig H, et al. Contemporary Surgical Management of Aberrant Right Subclavian Arteries (Arteria Lusoria). Ann Vasc Surg. 2020. PMID: 32949736. doi:10.1016/j.avsg.2020.08.151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。